Publications:

Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology

Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J

Publication Date: 2021-09-26

Variant appearance in text: HER2: P707T

PubMed Link: 34564954

Variant Present in the following documents:

• Main text
• MOL2-16-116.pdf

View BVdb publication page

Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology

Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J

Publication Date: 2022-01

Variant appearance in text: HER2: P707T

PubMed Link: 34564954

Variant Present in the following documents:

• Main text
• MOL2-16-116.pdf

View BVdb publication page

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.

Communications Biology

Nagasawa, Satoi S; Kuze, Yuta Y; Maeda, Ichiro I; Kojima, Yasuyuki Y; Motoyoshi, Ai A; Onishi, Tatsuya T; Iwatani, Tsuguo T; Yokoe, Takamichi T; Koike, Junki J; Chosokabe, Motohiro M; Kubota, Manabu M; Seino, Hibiki H; Suzuki, Ayako A; Seki, Masahide M; Tsuchihara, Katsuya K; Inoue, Eisuke E; Tsugawa, Koichiro K; Ohta, Tomohiko T; Suzuki, Yutaka Y

Publication Date: 2021-04-01

Variant appearance in text: ERBB2: P707T

PubMed Link: 33795819

Variant Present in the following documents:

• 42003_2021_1959_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page